Sarepta Therapeutics(SRPT) - 2024 Q4 - Earnings Call Transcript

Sarepta Therapeutics (SRPT) Q4 2024 Earnings Call February 27, 2025 08:39 AM ET Company Participants Mary Jenkins - Senior Manager of Investor RelationsDouglas Ingram - President & CEODallan Murray - EVP & Chief Customer OfficerLouise Rodino-Klapac - EVP, Chief Scientific Officer & Head Of R&DIan Estepan - EVP & CFOTazeen Ahmad - MD - US Equity ResearchGena Wang - MD - Biotech Equity ResearchKevin Meli - Equity Research AssociateAndrew Tsai - SVPKostas Biliouris - Director - Equity ResearchJoseph Schwartz - ...